首页> 外国专利> 3-(4-Substituted piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as neurokinin receptor (NK1 and NK2) antagonists

3-(4-Substituted piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as neurokinin receptor (NK1 and NK2) antagonists

机译:3-(4-取代的哌啶基-1)-1-(3,4-二氯苯基)丙基氨基甲酸酯和脲和衍生物作为神经激肽受体(NK1和NK2)拮抗剂

摘要

Piperidine compounds, 3-(4-subst.-piperidinyl-1)-1-(3, 4-dichlorophenyl)propyl carbamates and ureas as defined in the specification, their N-oxides, and their pharmaceutically acceptable salts, useful for the treatment of asthma and related conditions. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of the above formula and its intermediates. The piperidine derivatives antagonize the pharmacological actions of the endogenous neuropeptide tachykinins such as SP, neurokinin A (NKA) and neurokinin b (NKB), more specifically, neurokinin 1 (NK1) and neurokinin 2 (NK2).
机译:本说明书中定义的哌啶化合物,3-(4-亚甲基-哌啶基-1)-1-(3,4-二氯苯基)丙基氨基甲酸酯和脲,其N-氧化物和可药用盐可用于治疗哮喘和相关疾病。还公开了药物组合物,制备上式化合物及其中间体的方法。哌啶衍生物拮抗内源性神经肽速激肽如SP,神经激肽A(NKA)和神经激肽b(NKB),更具体地说,神经激肽1(NK1)和神经激肽2(NK2)的药理作用。

著录项

  • 公开/公告号NZ322147A

    专利类型

  • 公开/公告日2000-04-28

    原文格式PDF

  • 申请/专利权人 ZENECA LIMITED;

    申请/专利号NZ19960322147

  • 申请日1996-11-15

  • 分类号C07D211/52;C07D211/62;C07D401/04;C07D211/76;A61K31/445;C07D211/66;C07D211/58;

  • 国家 NZ

  • 入库时间 2022-08-22 01:55:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号